Vitamin D mitigates the adverse effects of obesity on breast cancer in mice. Read more about Vitamin D mitigates the adverse effects of obesity on breast cancer in mice.
Nuclear KLLN expression associates with improved relapse-free survival for prostate carcinoma. Read more about Nuclear KLLN expression associates with improved relapse-free survival for prostate carcinoma.
Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide. Read more about Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide.
The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors. Read more about The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors.
Contextual effect of repression of bone morphogenetic protein activity in prostate cancer. Read more about Contextual effect of repression of bone morphogenetic protein activity in prostate cancer.
Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study. Read more about Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.
Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort. Read more about Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.
The risk of metachronous cancers in patients with small-intestinal carcinoid tumors: a US population-based study. Read more about The risk of metachronous cancers in patients with small-intestinal carcinoid tumors: a US population-based study.
MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets. Read more about MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.
The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestine. Read more about The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestine.
